<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02312323</url>
  </required_header>
  <id_info>
    <org_study_id>CM-001-002</org_study_id>
    <nct_id>NCT02312323</nct_id>
  </id_info>
  <brief_title>One-month Clinical Evaluation of Silicone Hydrogel Definitive 65 HPT Contact Lenses</brief_title>
  <official_title>One-month Clinical Evaluation of Silicone Hydrogel Definitive 65 HPT Contact Lenses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Contamac Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hartwig Research Center</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Contamac Ltd</source>
  <brief_summary>
    <textblock>
      Comparison of different contact lens materials.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a 1-month, open-label, bilateral, parallel-group, randomised, daily wear study.&#xD;
      Two-thirds of the subjects will wear the Test lenses in both eyes, and one-third will wear&#xD;
      the Control lenses in both eyes.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 8, 2014</start_date>
  <completion_date type="Actual">May 23, 2015</completion_date>
  <primary_completion_date type="Actual">May 23, 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>questionnaire addressing subjective comfort and wear time</measure>
    <time_frame>subjects will be followed-up for one month</time_frame>
    <description>Subjects rated on a scale from 1 to 10, where 1 was 'poor' and 10 was 'excellent'.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>limbal redness - ocular biomicroscopy</measure>
    <time_frame>subjects will be followed-up for one month</time_frame>
    <description>Assessed using slit lamp with white light, low-medium magnification. Graded based on a grading scale which ranged from 0 to 4, where 0 is none, 1 is trace, 2 is mild, 3 is moderate and 4 is severe.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>conjunctival redness - ocular biomicroscopy</measure>
    <time_frame>subjects will be followed-up for one month</time_frame>
    <description>Assessed using slit lamp with white light, low-medium magnification. Graded based on a grading scale which ranged from 0 to 4, where 0 is none, 1 is trace, 2 is mild, 3 is moderate and 4 is severe.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>corneal staining - ocular biomicroscopy</measure>
    <time_frame>subjects will be followed-up for one month</time_frame>
    <description>Assessed using slit lamp with white light, low-medium magnification. Graded based on a grading scale which ranged from 0 to 4, where 0 is none, 1 is trace, 2 is mild, 3 is moderate and 4 is severe.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">35</enrollment>
  <condition>Ametropia</condition>
  <arm_group>
    <arm_group_label>Definitive 65 HPT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The Test product were the Definitive 65 (Filcon V4) lenses with Hydra PEG surface coating. This material is produced by Contamac Ltd. and the contact lenses were manufactured by Appenzeller Kontaktlinsen AG.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Definitive 65</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The Control product was the commercially available Definitive 65 (Efrofilcon A) lens. This material is produced by Contamac Ltd. and the contact lenses were manufactured by Appenzeller Kontaktlinsen AG.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Definitive 65 HPT contact lenses</intervention_name>
    <arm_group_label>Definitive 65 HPT</arm_group_label>
    <other_name>Filcon V4 (HPT)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Definitive 65 contact lenses</intervention_name>
    <arm_group_label>Definitive 65</arm_group_label>
    <other_name>Filcon V4</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  willing and able to sign informed consent form&#xD;
&#xD;
          -  ages 18 years or older&#xD;
&#xD;
          -  Subjects must have owned spectacles or contact lenses prior to enrolment for this&#xD;
             trial&#xD;
&#xD;
          -  Spherical power between -10.00 D and +10.00 D (at vertex distance 0 mm)&#xD;
&#xD;
          -  Astigmatic power ≤0.75 D&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Eye injury or surgery within 3 months immediately prior to enrolment for this trial&#xD;
&#xD;
          -  Pre-existing ocular irritation that would preclude contact lens fitting&#xD;
&#xD;
          -  Currently enrolled in an ophthalmic clinical trial&#xD;
&#xD;
          -  Evidence of systemic or ocular abnormality, infection or disease which is likely to&#xD;
             affect successful wear of contact lenses or use of the accessory solutions, as&#xD;
             determined by the investigator&#xD;
&#xD;
          -  Any use of medications for which contact lens wear could be contradicted, as&#xD;
             determined by the investigator&#xD;
&#xD;
          -  Current extended-wear users (sleep-in overnight)&#xD;
&#xD;
          -  Current monovision lens wearers&#xD;
&#xD;
          -  Pregnant women and nursing mothers&#xD;
&#xD;
          -  Best-corrected visual acuity worse than 6/9 (LogMAR: +0.20; Snellen decimal: 0.63)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andreas Hartwig, PhD, FAAO</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hartwig Research Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Siehste</name>
      <address>
        <city>Kassel</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kresinky</name>
      <address>
        <city>Würzburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>November 28, 2014</study_first_submitted>
  <study_first_submitted_qc>December 6, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 9, 2014</study_first_posted>
  <last_update_submitted>August 10, 2020</last_update_submitted>
  <last_update_submitted_qc>August 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Refractive Errors</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

